Arrow - Topirimate New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - topirimate

actavis new zealand limited - topiramate 200mg - film coated tablet - 200 mg - active: topiramate 200mg excipient: aniseed flavour 501007 bp0551 lactose magnesium stearate microcrystalline cellulose opadry pink 80w64830 pregelatinised maize starch purified water saccharin sodium sodium starch glycolate - arrow - topiramate is indicated in adults and children 2 years** and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome. **arrow-topiramate tablet range cannot deliver lower doses required for younger paediatric patients .

Arrow - Topirimate New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - topirimate

actavis new zealand limited - topiramate 50mg - film coated tablet - 50 mg - active: topiramate 50mg excipient: aniseed flavour 501007 bp0551 lactose magnesium stearate microcrystalline cellulose opadry yellow 80w62680 pregelatinised maize starch purified water saccharin sodium sodium starch glycolate - arrow - topiramate is indicated in adults and children 2 years** and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome. **arrow-topiramate tablet range cannot deliver lower doses required for younger paediatric patients .

Topamax New Zealand - English - Medsafe (Medicines Safety Authority)

topamax

janssen-cilag (new zealand) ltd - topiramate 100mg;  ;   - film coated tablet - 100 mg - active: topiramate 100mg     excipient: carnauba wax lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow ys-1-6370-g sodium starch glycolate starch - topamax is indicated in adults and children, 2 years and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

Topamax New Zealand - English - Medsafe (Medicines Safety Authority)

topamax

janssen-cilag (new zealand) ltd - topiramate 200mg;  ;   - film coated tablet - 200 mg - active: topiramate 200mg     excipient: carnauba wax lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink ys-1-1456-g as opadry pink ys-1-1759-g sodium starch glycolate starch - topamax is indicated in adults and children, 2 years and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

Topamax New Zealand - English - Medsafe (Medicines Safety Authority)

topamax

janssen-cilag (new zealand) ltd - topiramate 25mg;   - film coated tablet - 25 mg - active: topiramate 25mg   excipient: carnauba wax lactose monohydrate magnesium stearate microcrystalline cellulose opadry white ys-1-7706-g sodium starch glycolate starch - topamax is indicated in adults and children, 2 years and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

Topamax New Zealand - English - Medsafe (Medicines Safety Authority)

topamax

janssen-cilag (new zealand) ltd - topiramate 300mg;   - film coated tablet - 300 mg - active: topiramate 300mg   excipient: carnauba wax lactose monohydrate magnesium stearate microcrystalline cellulose opadry as opadry red ys-1-1759-g sodium starch glycolate starch

Topamax New Zealand - English - Medsafe (Medicines Safety Authority)

topamax

janssen-cilag (new zealand) ltd - topiramate 400mg;   - film coated tablet - 400 mg - active: topiramate 400mg   excipient: carnauba wax lactose monohydrate magnesium stearate microcrystalline cellulose opadry white ys-1-7706-g as opadry white ys-1-7706-g sodium starch glycolate starch

Topamax New Zealand - English - Medsafe (Medicines Safety Authority)

topamax

janssen-cilag (new zealand) ltd - topiramate 50mg;  ;   - film coated tablet - 50 mg - active: topiramate 50mg     excipient: carnauba wax lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow ys-1-6370-g sodium starch glycolate starch - topamax is indicated in adults and children, 2 years and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

Topamax Sprinkle New Zealand - English - Medsafe (Medicines Safety Authority)

topamax sprinkle

janssen-cilag (new zealand) ltd - topiramate 15mg;  ;   - capsule - 15 mg - active: topiramate 15mg     excipient: cellulose acetate gelatin opacode black s-1-17822 opacode black s-1-17823 povidone sucrose - topamax is indicated in adults and children, 2 years and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

Topamax Sprinkle New Zealand - English - Medsafe (Medicines Safety Authority)

topamax sprinkle

janssen-cilag (new zealand) ltd - topiramate 25mg;  ;   - capsule - 25 mg - active: topiramate 25mg     excipient: cellulose acetate gelatin opacode black s-1-17822 opacode black s-1-17823 povidone sucrose - topamax is indicated in adults and children, 2 years and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.